Literature DB >> 12498801

Biophysical properties of human antibody variable domains.

Stefan Ewert1, Thomas Huber, Annemarie Honegger, Andreas Plückthun.   

Abstract

There are great demands on the stability, expression yield and resistance to aggregation of antibody fragments. To untangle intrinsic domain effects from domain interactions, we present first a systematic evaluation of the isolated human immunoglobulin variable heavy (V(H)) and light (V(L)) germline family consensus domains and then a systematic series of V(H)-V(L) combinations in the scFv format. The constructs were evaluated in terms of their expression behavior, oligomeric state in solution and denaturant-induced unfolding equilibria under non-reducing conditions. The seven V(H) and seven V(L) domains represent the consensus sequences of the major human germline subclasses, derived from the Human Combinatorial Antibody Library (HuCAL). The isolated V(H) and V(L) domains with the highest thermodynamic stability and yield of soluble protein were V(H)3 and V(kappa)3, respectively. Similar measurements on all domain combinations in scFv fragments allowed the scFv fragments to be classified according to thermodynamic stability and in vivo folding yield. The scFv fragments containing the variable domain combinations H3kappa3, H1bkappa3, H5kappa3 and H3kappa1 show superior properties concerning yield and stability. Domain interactions diminish the intrinsic differences of the domains. ScFv fragments containing V(lambda) domains show high levels of stability, even though V(lambda) domains are surprisingly unstable by themselves. This is due to a strong interaction with the V(H) domain and depends on the amino acid sequence of the CDR-L3. On the basis of these analyses and model structures, we suggest possibilities for further improvement of the biophysical properties of individual frameworks and give recommendations for library design. Copyright 2003 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498801     DOI: 10.1016/s0022-2836(02)01237-8

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  97 in total

1.  General strategy for the generation of human antibody variable domains with increased aggregation resistance.

Authors:  Kip Dudgeon; Romain Rouet; Iris Kokmeijer; Peter Schofield; Jessica Stolp; David Langley; Daniela Stock; Daniel Christ
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

2.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

3.  Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.

Authors:  Andreas Lehmann; Josephine H F Wixted; Maxim V Shapovalov; Heinrich Roder; Roland L Dunbrack; Matthew K Robinson
Journal:  MAbs       Date:  2015-09-04       Impact factor: 5.857

4.  Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.

Authors:  Sue Townsend; Brian J Fennell; James R Apgar; Matthew Lambert; Barry McDonnell; Joanne Grant; Jason Wade; Edward Franklin; Niall Foy; Deirdre Ní Shúilleabháin; Conor Fields; Alfredo Darmanin-Sheehan; Amy King; Janet E Paulsen; Timothy P Hickling; Lioudmila Tchistiakova; Orla Cunningham; William J J Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

5.  Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.

Authors:  Thomas Hofer; Wisit Tangkeangsirisin; Michael G Kennedy; Rose G Mage; Stephen J Raiker; Karthik Venkatesh; Hakjoo Lee; Roman J Giger; Christoph Rader
Journal:  J Immunol Methods       Date:  2006-11-07       Impact factor: 2.303

6.  The library of human miniantibodies in the phage display format: designing and testing.

Authors:  A B Ulitin; M V Kapralova; A G Laman; A O Shepelyakovskaya; E V Bulgakova; K K Fursova; S G Abbasova; S K Volkov; F A Brovko; V A Nesmeyanov
Journal:  Dokl Biochem Biophys       Date:  2005 Nov-Dec       Impact factor: 0.788

7.  Oligovalent Fab display on M13 phage improved by directed evolution.

Authors:  Tuomas Huovinen; Hanna Sanmark; Jani Ylä-Pelto; Markus Vehniäinen; Urpo Lamminmäki
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

8.  A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.

Authors:  Dong-Ki Choi; Jeomil Bae; Seung-Min Shin; Ju-Yeon Shin; Sunghoon Kim; Yong-Sung Kim
Journal:  MAbs       Date:  2014       Impact factor: 5.857

9.  An improved single-chain Fab platform for efficient display and recombinant expression.

Authors:  James T Koerber; Michael J Hornsby; James A Wells
Journal:  J Mol Biol       Date:  2014-12-03       Impact factor: 5.469

10.  Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.

Authors:  Kathy Zhang; Melissa L Geddie; Neeraj Kohli; Tad Kornaga; Dmitri B Kirpotin; Yang Jiao; Rachel Rennard; Daryl C Drummond; Ulrik B Nielsen; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.